High Durable CR Rates in Relapsed/Refractory (R/R) Aggressive B-NHL Treated with the CD19-Directed CAR T Cell Product JCAR017 (TRANSCEND NHL 001): Defined Composition Allows for Dose-Finding and Definition of Pivotal Cohort
暂无分享,去创建一个
Michael L. Wang | L. Gordon | D. Maloney | A. Forero | M. Lunning | T. Siddiqi | J. Abramson | Tina M. Albertson | M. Palomba | J. Arnason | Daniel H. Li | Jacob Garcia | B. Xie | T. Albertson